Abilities

Compare
Page 1 of 1

Cold Resistance 1

Pathogen evolves to withstand cold temperatures and climates

8DNA

Cold Resistance 2

Lower intracellular water volume prevents freezing. Increased effectiveness in cold climates

14DNA

Drug Resistance 1

Pathogen becomes resistant to class 1 and 2 antibacterials. Increase effectiveness in wealthy countries

11DNA

Drug Resistance 2

Pathogen develops resistance to class 3 and 4 antibacterials. Increase effectiveness in wealthy countries

17DNA

Drug Resistance 3

Pathogen develops resistance to specialist Leprosy treatments. Increase effectiveness in wealthy countries

25DNA

Environmental Hardening

Pathogen develops hardened coating - becoming highly weather resistant and extremely comfortable in both hot and cold climates

61DNA

Genetic Hardening 1

Pathogen becomes harder to analyse in the lab. Decreases future research speed

9DNA

Genetic Hardening 2

The pathogen does not reproduce in lab conditions. Decreases future research speed

25DNA

Genetic Overhaul

DNA adapts to immune system attacks and is able to infect people at an effective rate. Significantly increases infectivity increase speed

16DNA

Genetic ReShuffle 1

Pathogen DNA strands reassembled. More work needed to develop a cure

16DNA

Genetic ReShuffle 2

A new strain of the pathogen now exists, increasing the work needed to develop a cure

21DNA

Genetic ReShuffle 3

Multiple strains of the pathogen now exist, increasing the work needed to develop a cure

24DNA

Heat Resistance 1

Pathogen evolves to withstand hot temperatures and climates

12DNA

Heat Resistance 2

Pathogen avoids cellular breakdown in high temperatures. Increased effectiveness in hot climates

24DNA

Incubation 1

An inconsistent and long-incubation period reduces chance of diagnosis, reducing severity but increasing effectiveness of treatment.

29DNA

Incubation 2

Increase Incubation time and decrease symptomatic time, less severity and increases the opportunity for infection

6DNA

Incubation 3

Maximise incubation time and minimise symptomatic time, significantly less severity and increases the opportunity for infection

9DNA